A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial
Clinical trial NCT06026254 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06026254
- Sponsor
- ImmuneSensor Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2025-09-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.